Consequently, expression of BCL2L2 was significantly higher in GBM than in low-grade gliomas103,104, and BCL-w was involved in an aggressive phenotype of glioblastoma cells associated with specificity protein 1 (Sp1)-dependent expression of stem cell-related markers104. This evidence concerns the gene BCL2L2 and glioblastoma.